Why the study?
What are the vascular and cardiovascular complications associated with cancer chemotherapy?
What are the vascular and cardiovascular complications associated with cancer chemotherapy?
This review highlights the growing need for cardio-oncology collaboration to manage the cardiovascular toxicities, particularly vascular complications, associated with both traditional and modern cancer chemotherapies.
No takes yet. Share an insight, caveat, or question.
May support cardio-oncology integration for VEGF inhibitor monitoring; leaves open optimal protocols pending prospective trials.
Cameron et al. (2015) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: